PH&T S.p.A. Report issue

For profit Phase 3
Founded: Milan Italy (1991)
Status: Acquired by Mayne Pharma (2005)

Organization Overview

First Clinical Trial
2012
NCT01702103
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

mometasone (elocon) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Nasal Obstruction (Phase 3)

Sneezing (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1